Showing results (1021-1030 of 1,079) with videos related to

Sort By:
Pageof 108
Communications Biology|June 1, 2022
Genetic architecture of band neutrophil fraction in IcelandGudjon R Oskarsson, Magnus K Magnusson, Asmundur Oddsson, et al.
Nature|October 4, 2023
Large-scale plasma proteomics comparisons through genetics and disease associationsGrimur Hjorleifsson Eldjarn, Egil Ferkingstad, Sigrun H Lund, et al.
European Journal of Preventive Cardiology|September 20, 2022
Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysisAnna Helgadottir, Gudmar Thorleifsson, Audunn Snaebjarnarson, et al.
Nature Communications|February 5, 2022
Population-level deficit of homozygosity unveils CPSF3 as an intellectual disability syndrome geneGudny A Arnadottir, Asmundur Oddsson, Brynjar O Jensson, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2011
Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitorsJohn L Buchanan, John R Newcomb, David P Carney, et al.
JAMA|August 22, 2023
Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular EventsHannes Helgason, Thjodbjorg Eiriksdottir, Magnus O Ulfarsson, et al.
Nature Genetics|October 11, 2011
Identification of low-frequency variants associated with gout and serum uric acid levelsPatrick Sulem, Daniel F Gudbjartsson, G Bragi Walters, et al.
Nature Communications|October 27, 2018
A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous diseaseGudny A Arnadottir, Gudmundur L Norddahl, Steinunn Gudmundsdottir, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Common and Rare Sequence Variants Influencing Tumor Biomarkers in BloodSigurgeir Olafsson, Kristjan F Alexandersson, Johann G K Gizurarson, et al.
Pageof 108